Michael Davis

6.4k total citations
33 papers, 1.1k citations indexed

About

Michael Davis is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, Michael Davis has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 8 papers in Rheumatology and 6 papers in Surgery. Recurrent topics in Michael Davis's work include Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (11 papers) and Urologic and reproductive health conditions (6 papers). Michael Davis is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (11 papers) and Urologic and reproductive health conditions (6 papers). Michael Davis collaborates with scholars based in United Kingdom, United States and Sweden. Michael Davis's co-authors include Jenny Donovan, David E. Neal, Freddie C. Hamdy, J. Athene Lane, Chris Metcalfe, Richard M. Martin, Mario Sofer, Sandy S. Kim, Mark S. Soloway and Kerry Avery and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Michael Davis

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Davis United Kingdom	17	698	215	193	190	160	33	1.1k
Greg Shaw United Kingdom	24	742 1.1×	186 0.9×	170 0.9×	209 1.1×	326 2.0×	76	1.3k
Raymond Lance United States	22	853 1.2×	188 0.9×	108 0.6×	168 0.9×	265 1.7×	40	1.2k
Simon Brewster United Kingdom	21	593 0.8×	264 1.2×	138 0.7×	262 1.4×	529 3.3×	59	1.5k
Peter Ka‐Fung Chiu Hong Kong	20	795 1.1×	189 0.9×	180 0.9×	262 1.4×	289 1.8×	135	1.4k
Karol Axcrona Norway	22	654 0.9×	245 1.1×	128 0.7×	140 0.7×	248 1.6×	63	1.2k
Ove Gustafsson Sweden	26	662 0.9×	225 1.0×	138 0.7×	242 1.3×	576 3.6×	56	1.7k
Mindaugas Jievaltas Lithuania	14	1.0k 1.4×	217 1.0×	107 0.6×	118 0.6×	181 1.1×	65	1.3k
Anna Kettermann United States	15	1.1k 1.6×	179 0.8×	183 0.9×	343 1.8×	107 0.7×	27	1.4k
Tatsuo Tochigi Japan	21	708 1.0×	175 0.8×	186 1.0×	188 1.0×	175 1.1×	61	999
Anton J. Bueschen United States	19	1.1k 1.6×	302 1.4×	204 1.1×	293 1.5×	291 1.8×	49	1.8k

Countries citing papers authored by Michael Davis

Since Specialization

Citations

This map shows the geographic impact of Michael Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Davis more than expected).

Fields of papers citing papers by Michael Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Davis. The network helps show where Michael Davis may publish in the future.

Co-authorship network of co-authors of Michael Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Davis. A scholar is included among the top collaborators of Michael Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Davis. Michael Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hochheiser, Harry, et al.. (2019). bd2kccd/py-causal v1.2.1. Zenodo (CERN European Organization for Nuclear Research). 3 indexed citations

Gilbert, Rebecca, Kate Tilling, Richard M. Martin, et al.. (2018). Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer. Cancer Causes & Control. 29(3). 383–388. 9 indexed citations

Harrison, Sean, Kate Tilling, Emma L. Turner, et al.. (2016). Investigating the prostate specific antigen, body mass index and age relationship: is an age–BMI-adjusted PSA model clinically useful?. Cancer Causes & Control. 27(12). 1465–1474. 14 indexed citations

Bryant, Richard J., Daniel D. Sjoberg, Andrew J. Vickers, et al.. (2015). Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study. JNCI Journal of the National Cancer Institute. 107(7). 123 indexed citations

Lane, J. Athene, Jenny Donovan, Michael Davis, et al.. (2014). Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. The Lancet Oncology. 15(10). 1109–1118. 135 indexed citations

Avery, Kerry, Jenny Donovan, Rebecca Gilbert, et al.. (2013). Men with prostate cancer make positive dietary changes following diagnosis and treatment. Cancer Causes & Control. 24(6). 1119–1128. 32 indexed citations

Burton, Anya, Richard M. Martin, Jenny Donovan, et al.. (2012). Associations of Lifestyle Factors and Anthropometric Measures with Repeat PSA Levels During Active Surveillance/Monitoring. Cancer Epidemiology Biomarkers & Prevention. 21(10). 1877–1885. 16 indexed citations

Rosario, Derek J., J. Athene Lane, Chris Metcalfe, et al.. (2012). Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ. 344(jan09 1). d7894–d7894. 189 indexed citations

Avery, Kerry, Chris Metcalfe, Kavita Vedhara, et al.. (2012). Predictors of Attendance for Prostate-Specific Antigen Screening Tests and Prostate Biopsy. European Urology. 62(4). 649–655. 23 indexed citations

10.

Catto, James W.F., Mary Robinson, Peter C. Albertsen, et al.. (2011). Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study. British Journal of Cancer. 105(7). 931–937. 15 indexed citations

11.

Turner, Emma L., J. Athene Lane, Jenny Donovan, et al.. (2010). Association of diabetes mellitus with prostate cancer: Nested case–control study (Prostate testing for cancer and Treatment study). International Journal of Cancer. 128(2). 440–446. 51 indexed citations

12.

Lewis, Sarah J., Lina Chen, George Davey Smith, et al.. (2010). Associations between an Obesity Related Genetic Variant (FTO rs9939609) and Prostate Cancer Risk. PLoS ONE. 5(10). e13485–e13485. 53 indexed citations

13.

Collin, Simon M., Chris Metcalfe, Jenny Donovan, et al.. (2009). Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: A case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study. European Journal of Cancer. 45(18). 3254–3261. 7 indexed citations

14.

Tilling, Kate, Hans Garmo, Chris Metcalfe, et al.. (2009). Development of a New Method for Monitoring Prostate-Specific Antigen Changes in Men with Localised Prostate Cancer: A Comparison of Observational Cohorts. European Urology. 57(3). 446–452. 12 indexed citations

15.

Chen, Lina, George Davey Smith, David M. Evans, et al.. (2009). Genetic Variants in the Vitamin D Receptor Are Associated with Advanced Prostate Cancer at Diagnosis: Findings from the Prostate Testing for Cancer and Treatment Study and a Systematic Review. Cancer Epidemiology Biomarkers & Prevention. 18(11). 2874–2881. 58 indexed citations

16.

Collin, Simon M., Chris Metcalfe, Jenny Donovan, et al.. (2008). Associations of lower urinary tract symptoms with prostate‐specific antigen levels, and screen‐detected localized and advanced prostate cancer: a case‐control study nested within the UK population‐based ProtecT (Prostate testing for cancer and Treatment) study. British Journal of Urology. 102(10). 1400–1406. 41 indexed citations

17.

Zuccolo, Luisa, R. Cole Harris, David Gunnell, et al.. (2008). Height and Prostate Cancer Risk: A Large Nested Case-Control Study (ProtecT) and Meta-analysis. Cancer Epidemiology Biomarkers & Prevention. 17(9). 2325–2336. 66 indexed citations

18.

Mills, Nicola, Chris Metcalfe, Carine Ronsmans, et al.. (2006). A comparison of socio-demographic and psychological factors between patients consenting to randomisation and those selecting treatment (the ProtecT study). Contemporary Clinical Trials. 27(5). 413–419. 20 indexed citations

19.

Davis, Michael, et al.. (2002). Crisis on Campus: Confronting Academic Misconduct. Academe. 88(4). 69–69. 27 indexed citations

20.

Warren, Steve, Youseph Yazdi, Ashley J. Welch, et al.. (1995). Combined ultrasound and fluorescence spectroscopy for physico-chemical imaging of atherosclerosis. IEEE Transactions on Biomedical Engineering. 42(2). 121–132. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact